The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-(5-(4-(4-isopropoxyphenylsulfonyl)piperazin-1-yl)-2-(nicotinamido)phenoxy)acetic acid ID: ALA3972788
PubChem CID: 134154521
Max Phase: Preclinical
Molecular Formula: C27H30N4O7S
Molecular Weight: 554.63
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CC(C)Oc1ccc(S(=O)(=O)N2CCN(c3ccc(NC(=O)c4cccnc4)c(OCC(=O)O)c3)CC2)cc1
Standard InChI: InChI=1S/C27H30N4O7S/c1-19(2)38-22-6-8-23(9-7-22)39(35,36)31-14-12-30(13-15-31)21-5-10-24(25(16-21)37-18-26(32)33)29-27(34)20-4-3-11-28-17-20/h3-11,16-17,19H,12-15,18H2,1-2H3,(H,29,34)(H,32,33)
Standard InChI Key: WSFKXTJEXGHTGR-UHFFFAOYSA-N
Molfile:
RDKit 2D
39 42 0 0 0 0 0 0 0 0999 V2000
8.1967 -16.3810 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.6094 -17.0909 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
9.0178 -16.3785 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.3734 -18.7335 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3723 -19.5530 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0803 -19.9620 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7900 -19.5525 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7872 -18.7299 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0786 -18.3246 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4908 -18.3187 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.1999 -18.7268 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9040 -18.3190 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9051 -17.5015 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.1960 -17.0934 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4858 -17.5028 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0801 -20.7791 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.3723 -21.1876 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3721 -22.0048 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6643 -22.4132 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.0797 -22.4135 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.3205 -17.5015 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3165 -18.3177 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0234 -18.7262 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7321 -18.3176 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7295 -17.4962 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0220 -17.0913 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4403 -18.7253 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.1475 -18.3157 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8557 -18.7234 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1464 -17.4985 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6643 -19.9610 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.9569 -19.5519 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2489 -19.9599 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9575 -18.7347 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.5402 -19.5521 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8326 -19.9595 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8315 -20.7776 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5439 -21.1866 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.2485 -20.7768 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 4 1 0
10 11 1 0
10 15 1 0
11 12 1 0
12 13 1 0
13 14 1 0
14 15 1 0
8 10 1 0
6 16 1 0
16 17 1 0
17 18 1 0
18 19 1 0
18 20 2 0
13 2 1 0
2 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 21 1 0
24 27 1 0
27 28 1 0
28 29 1 0
28 30 1 0
5 31 1 0
31 32 1 0
32 33 1 0
32 34 2 0
33 35 2 0
35 36 1 0
36 37 2 0
37 38 1 0
38 39 2 0
39 33 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 554.63Molecular Weight (Monoisotopic): 554.1835AlogP: 3.10#Rotatable Bonds: 10Polar Surface Area: 138.37Molecular Species: ACIDHBA: 8HBD: 2#RO5 Violations: 1HBA (Lipinski): 11HBD (Lipinski): 2#RO5 Violations (Lipinski): 2CX Acidic pKa: 3.13CX Basic pKa: 3.74CX LogP: 1.93CX LogD: -0.83Aromatic Rings: 3Heavy Atoms: 39QED Weighted: 0.39Np Likeness Score: -1.91
References 1. (2012) Sulfonamide derivative having PGD2 receptor antagonistic activity,